Benjamin Winkeljann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin Winkeljann has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Oliver Lieleg
TUM School of Engineering and Design, Department of Materials Engineering Technical University of Munich Garching Germany
17 shared publications - Olivia Monika Merkel
Ludwig-Maximilians-University Munich
10 shared publications - Thomas Crouzier
Division of Glycoscience Department of Chemistry School of Engineering Sciences in Chemistry Biotechnology and Health KTH Royal Institute of Technology AlbaNova University Center Stockholm 106 91 Sweden
6 shared publications - Job Boekhoven
School of Natural Sciences, Technical University of Munich, Lichtenbergstrasse 4, Garching, Germany, 85748
4 shared publications Oliver Lieleg
Department of Mechanical Engineering and Munich School of Bioengineering, Technical University of Munich, Garching, Germany
4 shared publicationsDavid C. Jürgens
Department of Pharmacy, Comprehensive Pneumology Center (CPC-M), Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL), 81377 Munich, Germany; RNhale GmbH, Am Klopferspitz 19, 82152 Planegg, Germany; Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Munich, Germany
3 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (21) , 6928-6935
Meta-Learning as a Promising Strategy for Lipid Nanoparticle Optimization and Ionizable Lipid Discovery
The rapid growth of lipid nanoparticle (LNP)-based RNA therapeutics demands predictive tools to accelerate formulation and lipid design, yet development remains limited by complex delivery mechanisms and scarce high-quality data. We investigated few-shot meta-learning (FSL) as a strategy for early stage, data-limited LNP development using a published data set. Meta-learning tasks were constructed from data provenance and formulation conditions, and several FSL methods were benchmarked against supervised baselines using fingerprint- and graph-based representations. In a stringent extrapolation setting, all siRNA data were excluded from meta-training and reserved for testing. Under this protocol, model-agnostic meta-learning (MAML) outperformed both supervised and transfer-learning baselines, achieving an average R2 of 0.38 ± 0.049 on the siRNA holdout task, whereas non-meta-learning models performed near zero. In retrospective active-learning simulations and experimental validation with 15 newly synthesized ionizable lipids across multiple cell lines and RNA cargos, MAML consistently surpassed random forest (RF), supporting FSL as a promising framework for data-scarce RNA delivery design tasks.
- 21 May 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (21) , 6928-6935
Open AccessMeta-Learning as a Promising Strategy for Lipid Nanoparticle Optimization and Ionizable Lipid Discovery
The rapid growth of lipid nanoparticle (LNP)-based RNA therapeutics demands predictive tools to accelerate formulation and lipid design, yet development remains limited by complex delivery mechanisms and scarce high-quality data. We investigated few-shot meta-learning (FSL) as a strategy for early stage, data-limited LNP development using a published data set. Meta-learning tasks were constructed from data provenance and formulation conditions, and several FSL methods were benchmarked against supervised baselines using fingerprint- and graph-based representations. In a stringent extrapolation setting, all siRNA data were excluded from meta-training and reserved for testing. Under this protocol, model-agnostic meta-learning (MAML) outperformed both supervised and transfer-learning baselines, achieving an average R2 of 0.38 ± 0.049 on the siRNA holdout task, whereas non-meta-learning models performed near zero. In retrospective active-learning simulations and experimental validation with 15 newly synthesized ionizable lipids across multiple cell lines and RNA cargos, MAML consistently surpassed random forest (RF), supporting FSL as a promising framework for data-scarce RNA delivery design tasks.
- Open Access
- 24 January 2026
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 709, 139973
Modulating mRNA carrier efficacy through the molecular catwalk of ionizable nitrogens in lipidic domains
- 24 January 2026
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 709, 139973
Open AccessModulating mRNA carrier efficacy through the molecular catwalk of ionizable nitrogens in lipidic domains
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (4) , 7718-7720
Correction to “Glyco-Modification of Mucin Hydrogels to Investigate Their Immune Activity”
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (4) , 7718-7720
Correction to “Glyco-Modification of Mucin Hydrogels to Investigate Their Immune Activity”
- Open Access
- 12 December 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 390, 114539
Understanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery
- 12 December 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 390, 114539
Open AccessUnderstanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery
- Open Access
- 26 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (49) , 44903-44915
From Bits to Bonds: High-Throughput Virtual Screening of Ribonucleic Acid Nanocarriers Using a Combinatorial Approach of Machine Learning and Molecular Dynamics
The implementation of high-throughput methods for fuelling the design of effective nanocarriers for RNA delivery remains challenging. Traditional experimental screening is resource-intensive, while purely computational approaches face limitations, such as data scarcity for machine learning models and the high computational cost of molecular dynamics simulations. This work introduces a high-throughput virtual screening platform, ″Bits2Bonds,″ integrating coarse-grained molecular dynamics simulations with machine learning-driven optimization to design novel poly(β-amino ester) (PBAE) carriers for therapeutic siRNA delivery. The platform evaluates virtual polymers using MD-based ″challenges″ that simulate key hurdles in nucleic acid delivery, such as membrane and siRNA interaction (association/dissociation). The computational framework was calibrated and validated against experimental data, including synthesis and characterization of four distinct PBAEs, logP measurements, siRNA encapsulation assays, and cell culture knockdown experiments. This integrated approach provides a powerful tool for the de novo design and rapid virtual screening of optimized polymeric siRNA delivery systems.
- 26 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (49) , 44903-44915
Open AccessFrom Bits to Bonds: High-Throughput Virtual Screening of Ribonucleic Acid Nanocarriers Using a Combinatorial Approach of Machine Learning and Molecular Dynamics
The implementation of high-throughput methods for fuelling the design of effective nanocarriers for RNA delivery remains challenging. Traditional experimental screening is resource-intensive, while purely computational approaches face limitations, such as data scarcity for machine learning models and the high computational cost of molecular dynamics simulations. This work introduces a high-throughput virtual screening platform, ″Bits2Bonds,″ integrating coarse-grained molecular dynamics simulations with machine learning-driven optimization to design novel poly(β-amino ester) (PBAE) carriers for therapeutic siRNA delivery. The platform evaluates virtual polymers using MD-based ″challenges″ that simulate key hurdles in nucleic acid delivery, such as membrane and siRNA interaction (association/dissociation). The computational framework was calibrated and validated against experimental data, including synthesis and characterization of four distinct PBAEs, logP measurements, siRNA encapsulation assays, and cell culture knockdown experiments. This integrated approach provides a powerful tool for the de novo design and rapid virtual screening of optimized polymeric siRNA delivery systems.
- Open Access
- 25 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (23) , 15856-15866
Design of an Injectable and Bioerodible Supramolecular Hydrogel as a Local Nucleic Acid Delivery System
- 25 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (23) , 15856-15866
Open AccessDesign of an Injectable and Bioerodible Supramolecular Hydrogel as a Local Nucleic Acid Delivery System
- Open Access
- 26 November 2024
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 24 (49) , 15683-15692
Molecular Dynamics Simulations Elucidate the Molecular Organization of Poly(beta-amino ester) Based Polyplexes for siRNA Delivery
Cationic polymers are known to efficiently deliver nucleic acids to target cells by encapsulating the cargo into nanoparticles. However, the molecular organization of these nanoparticles is often not fully explored. Yet, this information is crucial to understand complex particle systems and the role influencing factors play at later stages of drug development. Coarse-grained molecular dynamics (CG-MD) enables modeling of systems that are the size of real nanoparticles, providing meaningful insights into molecular interactions between polymers and nucleic acids. Herein, the particle assembly of variations of an amphiphilic poly(beta-amino ester) (PBAE) with siRNA was simulated to investigate the influence of factors such as polymer lipophilicity and buffer conditions on the nanoparticle structure. Simulations were validated by wet lab methods including nuclear magnetic resonance (NMR) and align well with experimental findings. Therefore, this work emphasizes that CG-MD simulations can provide underlying explanations of experimentally observed nanoparticle properties by visualizing the nanoscale structure of polyplexes.
- 26 November 2024
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 24 (49) , 15683-15692
Open AccessMolecular Dynamics Simulations Elucidate the Molecular Organization of Poly(beta-amino ester) Based Polyplexes for siRNA Delivery
Cationic polymers are known to efficiently deliver nucleic acids to target cells by encapsulating the cargo into nanoparticles. However, the molecular organization of these nanoparticles is often not fully explored. Yet, this information is crucial to understand complex particle systems and the role influencing factors play at later stages of drug development. Coarse-grained molecular dynamics (CG-MD) enables modeling of systems that are the size of real nanoparticles, providing meaningful insights into molecular interactions between polymers and nucleic acids. Herein, the particle assembly of variations of an amphiphilic poly(beta-amino ester) (PBAE) with siRNA was simulated to investigate the influence of factors such as polymer lipophilicity and buffer conditions on the nanoparticle structure. Simulations were validated by wet lab methods including nuclear magnetic resonance (NMR) and align well with experimental findings. Therefore, this work emphasizes that CG-MD simulations can provide underlying explanations of experimentally observed nanoparticle properties by visualizing the nanoscale structure of polyplexes.
- Open Access
- 5 July 2024
- Published by OAE Publishing Inc. in Extracellular Vesicles and Circulating Nucleic Acids
- Vol. 5 (3) , 344-57
Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design
The rise of biologics and RNA-based therapies challenges the limitations of traditional drug treatments. However, these potent new classes of therapeutics require effective delivery systems to reach their full potential. Lipid nanoparticles (LNPs) have emerged as a promising solution for RNA delivery, but endosomal entrapment remains a critical barrier. In contrast, natural extracellular vesicles (EVs) possess innate mechanisms to overcome endosomal degradation, demonstrating superior endosomal escape (EE) compared to conventional LNPs. This mini review explores the challenges of EE for lipid nanoparticle-based drug delivery, and offers insights into EV escape mechanisms to advance LNP design for RNA therapeutics. We compare the natural EE strategies of EVs with those used in LNPs and highlight contemporary LNP design approaches. By understanding the mechanisms of EE, we will be able to develop more effective drug delivery vehicles, enhancing the delivery and efficacy of RNA-based therapies.
- 5 July 2024
- Published by OAE Publishing Inc. in Extracellular Vesicles and Circulating Nucleic Acids
- Vol. 5 (3) , 344-57
Open AccessEndosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design
The rise of biologics and RNA-based therapies challenges the limitations of traditional drug treatments. However, these potent new classes of therapeutics require effective delivery systems to reach their full potential. Lipid nanoparticles (LNPs) have emerged as a promising solution for RNA delivery, but endosomal entrapment remains a critical barrier. In contrast, natural extracellular vesicles (EVs) possess innate mechanisms to overcome endosomal degradation, demonstrating superior endosomal escape (EE) compared to conventional LNPs. This mini review explores the challenges of EE for lipid nanoparticle-based drug delivery, and offers insights into EV escape mechanisms to advance LNP design for RNA therapeutics. We compare the natural EE strategies of EVs with those used in LNPs and highlight contemporary LNP design approaches. By understanding the mechanisms of EE, we will be able to develop more effective drug delivery vehicles, enhancing the delivery and efficacy of RNA-based therapies.
- Open Access
- 11 April 2024
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 4 (7)
Behavior of Self‐Disintegrating Microparticles at the Air/Mucus Interface
In recent years, highly specialized nanoscopic drug carriers have been developed, which can, e.g., traverse biological barriers, protect drugs against harsh physiological conditions, and release such drugs in a controlled manner. However, for the delivery of particles via the respiratory pathway, aerodynamic diameters in the range of several micrometers are required to achieve good lung deposition and biodistribution. To combine the favorable properties of inhalable, micron‐sized particles with the advantages of nanosized drug carriers, herein, dry‐powder, hybrid microparticles (h‐μPs), which disintegrate upon contact with moist surfaces (as present in the lung) to release the embedded nanoparticles into the mucosa, are introduced. Furthermore, a microfluidic setup, which mimics the air–gel interface of the mucosal airway epithelium, is presented. With this setup, the interaction of airborne h‐μPs with the mucosal interface on a microscopic level is investigated. In detail, the influence of the h‐μP charge on their deposition efficiency is tested and it is found that this process is governed by a combination of electrostatic interactions between the mucosal surface and the h‐μPs as well as hygroscopic effects. Thus, this approach can help to optimize inhalable drug carriers to increase the efficiency of pulmonary drug administration via the respiratory pathway.
- 11 April 2024
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 4 (7)
Open AccessBehavior of Self‐Disintegrating Microparticles at the Air/Mucus Interface
In recent years, highly specialized nanoscopic drug carriers have been developed, which can, e.g., traverse biological barriers, protect drugs against harsh physiological conditions, and release such drugs in a controlled manner. However, for the delivery of particles via the respiratory pathway, aerodynamic diameters in the range of several micrometers are required to achieve good lung deposition and biodistribution. To combine the favorable properties of inhalable, micron‐sized particles with the advantages of nanosized drug carriers, herein, dry‐powder, hybrid microparticles (h‐μPs), which disintegrate upon contact with moist surfaces (as present in the lung) to release the embedded nanoparticles into the mucosa, are introduced. Furthermore, a microfluidic setup, which mimics the air–gel interface of the mucosal airway epithelium, is presented. With this setup, the interaction of airborne h‐μPs with the mucosal interface on a microscopic level is investigated. In detail, the influence of the h‐μP charge on their deposition efficiency is tested and it is found that this process is governed by a combination of electrostatic interactions between the mucosal surface and the h‐μPs as well as hygroscopic effects. Thus, this approach can help to optimize inhalable drug carriers to increase the efficiency of pulmonary drug administration via the respiratory pathway.
- Open Access
- 19 February 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (5) , 2163-2175
Closing the Gap between Experiment and Simulation─A Holistic Study on the Complexation of Small Interfering RNAs with Polyethylenimine
Rational design is pivotal in the modern development of nucleic acid nanocarrier systems. With the rising prominence of polymeric materials as alternatives to lipid-based carriers, understanding their structure-function relationships becomes paramount. Here, we introduce a newly developed coarse-grained model of polyethylenimine (PEI) based on the Martini 3 force field. This model facilitates molecular dynamics simulations of true-sized PEI molecules, exemplified by molecules with molecular weights of 1.3, 5, 10, and 25 kDa, with degrees of branching between 50.0 and 61.5%. We employed this model to investigate the thermodynamics of small interfering RNA (siRNA) complexation with PEI. Our simulations underscore the pivotal role of electrostatic interactions in the complexation process. Thermodynamic analyses revealed a stronger binding affinity with increased protonation, notably in acidic (endosomal) pH, compared to neutral conditions. Furthermore, the molecular weight of PEI was found to be a critical determinant of binding dynamics: smaller PEI molecules closely enveloped the siRNA, whereas larger ones extended outward, facilitating the formation of complexes with multiple RNA molecules. Experimental validations, encompassing isothermal titration calorimetry and single-molecule fluorescence spectroscopy, aligned well with our computational predictions. Our findings not only validate the fidelity of our PEI model but also accentuate the importance of in silico data in the rational design of polymeric drug carriers. The synergy between computational predictions and experimental validations, as showcased here, signals a refined and precise approach to drug carrier design.
- 19 February 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (5) , 2163-2175
Open AccessClosing the Gap between Experiment and Simulation─A Holistic Study on the Complexation of Small Interfering RNAs with Polyethylenimine
Rational design is pivotal in the modern development of nucleic acid nanocarrier systems. With the rising prominence of polymeric materials as alternatives to lipid-based carriers, understanding their structure-function relationships becomes paramount. Here, we introduce a newly developed coarse-grained model of polyethylenimine (PEI) based on the Martini 3 force field. This model facilitates molecular dynamics simulations of true-sized PEI molecules, exemplified by molecules with molecular weights of 1.3, 5, 10, and 25 kDa, with degrees of branching between 50.0 and 61.5%. We employed this model to investigate the thermodynamics of small interfering RNA (siRNA) complexation with PEI. Our simulations underscore the pivotal role of electrostatic interactions in the complexation process. Thermodynamic analyses revealed a stronger binding affinity with increased protonation, notably in acidic (endosomal) pH, compared to neutral conditions. Furthermore, the molecular weight of PEI was found to be a critical determinant of binding dynamics: smaller PEI molecules closely enveloped the siRNA, whereas larger ones extended outward, facilitating the formation of complexes with multiple RNA molecules. Experimental validations, encompassing isothermal titration calorimetry and single-molecule fluorescence spectroscopy, aligned well with our computational predictions. Our findings not only validate the fidelity of our PEI model but also accentuate the importance of in silico data in the rational design of polymeric drug carriers. The synergy between computational predictions and experimental validations, as showcased here, signals a refined and precise approach to drug carrier design.